The landscape of software development is undergoing a profound transformation, ushering in what many industry experts are calling the "agent-first"…
Read More
Bioengineered Bone Marrow Platform Replicates Human Immune System and Offers New Frontiers for Drug Development and Space Medicine
The human bone marrow serves as a silent but tireless factory, situated within the skeletal cavities, where it orchestrates the…
Read More
Vitestro Secures $70 Million in Oversubscribed Series B to Accelerate Autonomous Phlebotomy Development and Global Commercialization
Utrecht, Netherlands – Vitestro, a pioneering medical robotics company, has successfully closed an oversubscribed Series B financing round, securing an…
Read More
Simulations Plus Forges Strategic Alliances to Pioneer AI-Driven Drug Development
Simulations Plus, a leading provider of advanced modeling and simulation software for drug discovery and development, has announced the establishment…
Read More
Seven Free Web APIs Revolutionizing AI Agent Development with Real-Time Web Access
The rapid acceleration of artificial intelligence (AI) capabilities has underscored a critical necessity: the ability for AI applications to interact…
Read More
Daiichi Sankyo and Tempus AI collaborate on ADC clinical development
In a significant move poised to accelerate the innovation pipeline for antibody-drug conjugate (ADC) therapies, Japanese pharmaceutical giant Daiichi Sankyo…
Read More
Development of an ultra-sensitive human cardiac troponin I sandwich ELISA
In a significant advancement poised to reshape the landscape of cardiac biomarker detection, Exazym®’s innovative BOLD (Binding Oligo Ladder Detection)…
Read More
Monash University and ClinChoice Forge Strategic Alliance to Accelerate Therapeutic Development and Enhance Patient Access to Novel Treatments
Australia’s Monash University, a leading research institution, and ClinChoice, a global contract research organization (CRO), have formally announced a significant…
Read More
First Blueprint of Human Skeletal Development Reveals Cellular Origins of Arthritis and Congenital Bone Conditions
Researchers from the Wellcome Sanger Institute and their international collaborators have achieved a significant scientific milestone by mapping the first…
Read More
JAMA Study Uncovers Moderate Caffeine Intake’s Link to Reduced Dementia Risk, Highlighting Adenosine Pathway for Drug Development
A comprehensive prospective cohort study, published online on February 9, 2026, in the esteemed journal JAMA, has revealed a significant…
Read MoreYOU MAY HAVE MISSED
